[HTML][HTML] 6. The ALIVE Study, A Longitudinal Study Of HIV-1 Infection in Intravenous Drug Users: Description of Methods and Characteristics of
By 1985 the acquired immunodeficiency syndrome (AIDS) had been recognized as an
epidemic of major public health importance and the primary etiologic agent, human
immunodeficiency virus, type 1 (HIV-1), had been identified. At that time, major studies had
started to characterize the natural history of HIV-1 infection among homosexual/bisexual
men (Kaslow et al. 1987; Winklestein et al. 1987; Schechter et al. 1985), who accounted for
about 75 percent of the cases of AIDS (Centers for Disease Control 1986). However, the …
epidemic of major public health importance and the primary etiologic agent, human
immunodeficiency virus, type 1 (HIV-1), had been identified. At that time, major studies had
started to characterize the natural history of HIV-1 infection among homosexual/bisexual
men (Kaslow et al. 1987; Winklestein et al. 1987; Schechter et al. 1985), who accounted for
about 75 percent of the cases of AIDS (Centers for Disease Control 1986). However, the …
The ALIVE Study: a longitudinal study of HIV-1 infection in intravenous drug users: description of methods
To identify risk factors for infection with the human immunodeficiency virus (HIV) and for
progression to the acquired immunodeficiency syndrome (AIDS) among intravenous drug
users, we established a cohort in Baltimore Maryland in 1988–1989. Intravenous drug users
were recruited by extensive community outreach to undergo interview and confidential HIV
testing in a special study site. During 13 months of recruitment, 2,921 intravenous drug users
were enrolled of whome 24 percent were HIV seropositive; 90 percent returned to receive …
progression to the acquired immunodeficiency syndrome (AIDS) among intravenous drug
users, we established a cohort in Baltimore Maryland in 1988–1989. Intravenous drug users
were recruited by extensive community outreach to undergo interview and confidential HIV
testing in a special study site. During 13 months of recruitment, 2,921 intravenous drug users
were enrolled of whome 24 percent were HIV seropositive; 90 percent returned to receive …